596 related articles for article (PubMed ID: 22178561)
21. Glycoproteins in the Sera of Oncological Patients.
Hernychová L; Uhrík L; Nenutil R; Novotný MV
Klin Onkol; 2019; 32(Supplementum 3):39-45. PubMed ID: 31627705
[TBL] [Abstract][Full Text] [Related]
22. The sensitivity and specificity of serum glycan-based biomarkers for cancer detection.
Tang Y; Cui Y; Zhang S; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():121-140. PubMed ID: 30905445
[TBL] [Abstract][Full Text] [Related]
23. A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.
Narimatsu H; Sawaki H; Kuno A; Kaji H; Ito H; Ikehara Y
FEBS J; 2010 Jan; 277(1):95-105. PubMed ID: 19919546
[TBL] [Abstract][Full Text] [Related]
24. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry.
Sethi MK; Hancock WS; Fanayan S
Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation.
Arnold JN; Saldova R; Hamid UM; Rudd PM
Proteomics; 2008 Aug; 8(16):3284-93. PubMed ID: 18646009
[TBL] [Abstract][Full Text] [Related]
26. Various sulfated carbohydrate tumor marker candidates identified by focused glycomic analyses.
Tanaka-Okamoto M; Mukai M; Takahashi H; Fujiwara Y; Ohue M; Miyamoto Y
Glycobiology; 2017 May; 27(5):400-415. PubMed ID: 28025252
[TBL] [Abstract][Full Text] [Related]
27. Glycoproteins and glycoproteomics in pancreatic cancer.
Pan S; Brentnall TA; Chen R
World J Gastroenterol; 2016 Nov; 22(42):9288-9299. PubMed ID: 27895417
[TBL] [Abstract][Full Text] [Related]
28. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
29. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
[TBL] [Abstract][Full Text] [Related]
30. N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.
Alley WR; Vasseur JA; Goetz JA; Svoboda M; Mann BF; Matei DE; Menning N; Hussein A; Mechref Y; Novotny MV
J Proteome Res; 2012 Apr; 11(4):2282-300. PubMed ID: 22304416
[TBL] [Abstract][Full Text] [Related]
31. Glycomics meets genomics, epigenomics and other high throughput omics for system biology studies.
Zoldoš V; Horvat T; Lauc G
Curr Opin Chem Biol; 2013 Feb; 17(1):34-40. PubMed ID: 23287290
[TBL] [Abstract][Full Text] [Related]
32. Functional impact of tumor-specific N-linked glycan changes in breast and ovarian cancers.
Guo H; Abbott KL
Adv Cancer Res; 2015; 126():281-303. PubMed ID: 25727151
[TBL] [Abstract][Full Text] [Related]
33. Identification of 34 N-glycan isomers in human serum by capillary electrophoresis coupled with laser-induced fluorescence allows improving glycan biomarker discovery.
Schwedler C; Kaup M; Weiz S; Hoppe M; Braicu EI; Sehouli J; Hoppe B; Tauber R; Berger M; Blanchard V
Anal Bioanal Chem; 2014 Nov; 406(28):7185-93. PubMed ID: 25234305
[TBL] [Abstract][Full Text] [Related]
34. [Sugars Interfere or Glycomics in the Field of Cancer Biomarkers].
Zahradníková M; Vojtěšek B; Hernychova L
Klin Onkol; 2015; 28 Suppl 2():2S20-5. PubMed ID: 26374154
[TBL] [Abstract][Full Text] [Related]
35. The clinical role of glycobiology on ovarian cancer progression.
Armbrister R; Ochoa L; Abbott KL
Adv Cancer Res; 2023; 157():1-22. PubMed ID: 36725106
[TBL] [Abstract][Full Text] [Related]
36. Developments in the identification of glycan biomarkers for the detection of cancer.
Ruhaak LR; Miyamoto S; Lebrilla CB
Mol Cell Proteomics; 2013 Apr; 12(4):846-55. PubMed ID: 23365456
[TBL] [Abstract][Full Text] [Related]
37. Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications.
Tikhonov A; Smoldovskaya O; Feyzkhanova G; Kushlinskii N; Rubina A
Clin Chem Lab Med; 2020 Sep; 58(10):1611-1622. PubMed ID: 32324152
[TBL] [Abstract][Full Text] [Related]
38. Identification of unique glycoisoforms of vitamin D-binding protein and haptoglobin as biomarker candidates in hepatocarcinogenesis of STAM mice.
Yoshida Y; Furukawa JI; Naito S; Higashino K; Numata Y; Shinohara Y
Glycoconj J; 2018 Oct; 35(5):467-476. PubMed ID: 30194503
[TBL] [Abstract][Full Text] [Related]
39. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
Taniguchi N; Kizuka Y
Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
[TBL] [Abstract][Full Text] [Related]
40. Glycomics-driven discoveries in schistosome research.
Hokke CH; Deelder AM; Hoffmann KF; Wuhrer M
Exp Parasitol; 2007 Nov; 117(3):275-83. PubMed ID: 17659278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
